{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T12:29:53Z","timestamp":1769084993289,"version":"3.49.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:00:00Z","timestamp":1761177600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:00:00Z","timestamp":1761177600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No. 82173353"],"award-info":[{"award-number":["No. 82173353"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Surg Endosc"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s00464-025-12330-y","type":"journal-article","created":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T16:45:16Z","timestamp":1761237916000},"page":"424-433","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comparison of apixaban and warfarin in preventing portal vein system thrombosis after laparoscopic splenectomy for cirrhotic patients with secondary hypersplenism: a randomized controlled trial"],"prefix":"10.1007","volume":"40","author":[{"given":"Tian-Ming","family":"Gao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kun-Qing","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liu-Xin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bing-Bing","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheng-Jie","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bao-Huan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dou-Sheng","family":"Bai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8699-6624","authenticated-orcid":false,"given":"Guo-Qing","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,23]]},"reference":[{"key":"12330_CR1","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s12967-017-1214-8","volume":"15","author":"L Li","year":"2017","unstructured":"Li L, Duan M, Chen W, Jiang A, Li X, Yang J, Li Z (2017) The spleen in liver cirrhosis: revisiting an old enemy with novel targets. J Transl Med 15:111","journal-title":"J Transl Med"},{"key":"12330_CR2","doi-asserted-by":"publisher","first-page":"2377","DOI":"10.3892\/etm.2016.3683","volume":"12","author":"Y Lv","year":"2016","unstructured":"Lv Y, Lau WY, Li Y, Deng J, Han X, Gong X, Liu N, Wu H (2016) Hypersplenism: history and current status. Exp Ther Med 12:2377\u20132382","journal-title":"Exp Ther Med"},{"key":"12330_CR3","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1111\/liv.13317","volume":"37","author":"M Peck-Radosavljevic","year":"2017","unstructured":"Peck-Radosavljevic M (2017) Thrombocytopenia in chronic liver disease. Liver Int 37:778\u2013793","journal-title":"Liver Int"},{"key":"12330_CR4","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1097\/SLE.0b013e3181a6ec7c","volume":"19","author":"JH Zhu","year":"2009","unstructured":"Zhu JH, Wang YD, Ye ZY, Zhao T, Zhu YW, Xie ZJ, Liu JM (2009) Laparoscopic versus open splenectomy for hypersplenism secondary to liver cirrhosis. Surg Laparosc Endosc Percutan Tech 19:258\u2013262","journal-title":"Surg Laparosc Endosc Percutan Tech"},{"key":"12330_CR5","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1007\/s11605-023-05610-2","volume":"27","author":"Q Zhu","year":"2023","unstructured":"Zhu Q, Chen D, Lou Y, Xie X, Wu Y, Wang Z, Sun H (2023) Baseline ALBI grade predicts benefits after splenectomy for cirrhotic patients with hypersplenism. J Gastrointest Surg 27:1130\u20131140","journal-title":"J Gastrointest Surg"},{"key":"12330_CR6","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1002\/bjs.7002","volume":"97","author":"N Kinjo","year":"2010","unstructured":"Kinjo N, Kawanaka H, Akahoshi T, Tomikawa M, Yamashita N, Konishi K, Tanoue K, Shirabe K, Hashizume M, Maehara Y (2010) Risk factors for portal venous thrombosis after splenectomy in patients with cirrhosis and portal hypertension. Br J Surg 97:910\u2013916","journal-title":"Br J Surg"},{"key":"12330_CR7","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1016\/j.jhep.2004.01.001","volume":"40","author":"L Amitrano","year":"2004","unstructured":"Amitrano L, Guardascione MA, Brancaccio V, Margaglione M, Manguso F, Iannaccone L, Grandone E, Balzano A (2004) Risk factors and clinical presentation of portal vein thrombosis in patients with liver cirrhosis. J Hepatol 40:736\u2013741","journal-title":"J Hepatol"},{"key":"12330_CR8","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1097\/SLE.0000000000000710","volume":"29","author":"D Huang","year":"2019","unstructured":"Huang D, Tao M, Cao L, Wang X, Zheng S, Cao Y (2019) Risk factors and anticoagulation effects of portal vein system thrombosis after laparoscopic splenectomy in patients with or without cirrhosis. Surg Laparosc Endosc Percutan Tech 29:498\u2013502","journal-title":"Surg Laparosc Endosc Percutan Tech"},{"key":"12330_CR9","doi-asserted-by":"publisher","first-page":"476","DOI":"10.5604\/01.3001.0011.7392","volume":"17","author":"V Cruz-Ram\u00f3n","year":"2018","unstructured":"Cruz-Ram\u00f3n V, Chinchilla-L\u00f3pez P, Ram\u00edrez-P\u00e9rez O, Aguilar-Olivos NE, Alva-L\u00f3pez LF, Fajardo-Ordo\u00f1ez E, Ponciano-Rodr\u00edguez G, Northup PG, Intagliata N, Caldwell SH, Qi X, M\u00e9ndez-S\u00e1nchez N (2018) Thrombosis of the portal venous system in cirrhotic vs. non-cirrhotic patients. Ann Hepatol 17:476\u2013481","journal-title":"Ann Hepatol"},{"key":"12330_CR10","doi-asserted-by":"publisher","first-page":"2806","DOI":"10.1111\/ans.18633","volume":"93","author":"YK Lin","year":"2023","unstructured":"Lin YK, Cai XR, Hong HJ, Chen JZ, Chen YL, Du Q (2023) Risk factors of portal vein system thrombosis after splenectomy: a meta-analysis. ANZ J Surg 93:2806\u20132819","journal-title":"ANZ J Surg"},{"key":"12330_CR11","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.jhep.2021.04.029","volume":"75","author":"M Senzolo","year":"2021","unstructured":"Senzolo M, Garcia-Tsao G, Garc\u00eda-Pag\u00e1n JC (2021) Current knowledge and management of portal vein thrombosis in cirrhosis. J Hepatol 75:442\u2013453","journal-title":"J Hepatol"},{"key":"12330_CR12","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.jhep.2009.06.009","volume":"51","author":"JC Garcia-Pagan","year":"2009","unstructured":"Garcia-Pagan JC, Valla DC (2009) Portal vein thrombosis: a predictable milestone in cirrhosis? J Hepatol 51:632\u2013634","journal-title":"J Hepatol"},{"key":"12330_CR13","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/S2468-1253(24)00155-9","volume":"9","author":"L Elkrief","year":"2024","unstructured":"Elkrief L, Hernandez-Gea V, Senzolo M, Albillos A, Baiges A, Berzigotti A, Bureau C, Murad SD, De Gottardi A, Durand F, Garcia-Pagan JC, Lisman T, Mandorfer M, McLin V, Moga L, Nery F, Northup P, Nuzzo A, Paradis V, Patch D, Payanc\u00e9 A, Plaforet V, Plessier A, Poisson J, Roberts L, Salem R, Sarin S, Shukla A, Toso C, Tripathi D, Valla D, Ronot M, Rautou PE, ERN RARE-LIVER and VALDIG, an EASL consortium (2024) Portal vein thrombosis: diagnosis, management, and endpoints for future clinical studies. Lancet Gastroenterol Hepatol 9:859\u2013883","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"12330_CR14","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1097\/00007890-200005150-00023","volume":"69","author":"MA Yerdel","year":"2000","unstructured":"Yerdel MA, Gunson B, Mirza D, Karayal\u00e7in K, Olliff S, Buckels J, Mayer D, McMaster P, Pirenne J (2000) Portal vein thrombosis in adults undergoing liver transplantation: risk factors, screening, management, and outcome. Transplantation 69:1873\u20131881","journal-title":"Transplantation"},{"key":"12330_CR15","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.jhep.2015.07.040","volume":"64","author":"European Association for the Study of the Liver","year":"2016","unstructured":"European Association for the Study of the Liver (2016) EASL clinical practice guidelines: Vascular diseases of the liver. J Hepatol 64:179\u2013202","journal-title":"J Hepatol"},{"key":"12330_CR16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0290164","volume":"18","author":"Z Liao","year":"2023","unstructured":"Liao Z, Wang Z, Su C, Pei Y, Li W, Liu J (2023) Long term prophylactic anticoagulation for portal vein thrombosis after splenectomy: a systematic review and meta-analysis. PLoS ONE 18:e0290164","journal-title":"PLoS ONE"},{"key":"12330_CR17","doi-asserted-by":"publisher","first-page":"2671","DOI":"10.1007\/s10620-019-05572-z","volume":"64","author":"C Noronha Ferreira","year":"2019","unstructured":"Noronha Ferreira C, Reis D, Cortez-Pinto H, Tato Marinho R, Gon\u00e7alves A, Palma S, Leite I, Rodrigues T, Pedro AJ, Alexandrino P, Serejo F, Sobral Dias M, Ferreira P, Vasconcelos M, Dami\u00e3o F, Xavier Brito L, Baldaia C, Fatela N, Ramalho F, Velosa J (2019) Anticoagulation in cirrhosis and portal vein thrombosis is safe and improves prognosis in advanced cirrhosis. Dig Dis Sci 64:2671\u20132683","journal-title":"Dig Dis Sci"},{"key":"12330_CR18","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1056\/NEJMoa1302507","volume":"369","author":"G Agnelli","year":"2013","unstructured":"Agnelli G, Buller HR, Cohen A, Curto M, Gallus AS, Johnson M, Masiukiewicz U, Pak R, Thompson J, Raskob GE, Weitz JI, AMPLIFY Investigators (2013) Oral apixaban for the treatment of acute venous thromboembolism. N Engl J Med 369:799\u2013808","journal-title":"N Engl J Med"},{"key":"12330_CR19","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.ijcard.2021.07.005","volume":"339","author":"MC Vedovati","year":"2021","unstructured":"Vedovati MC, Tratar G, Mavri A, Mazzetti M, Salazar Rosa V, Pierpaoli L, Cotugno M, Agnelli G, Becattini C (2021) Upper extremities deep vein thrombosis treated with oral direct anticoagulants: a prospective cohort study. Int J Cardiol 339:158\u2013163","journal-title":"Int J Cardiol"},{"key":"12330_CR20","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.c332","volume":"340","author":"KF Schulz","year":"2010","unstructured":"Schulz KF, Altman DG, Moher D, CONSORT Group (2010) CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMJ 340:c332","journal-title":"BMJ"},{"key":"12330_CR21","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/s00464-013-3182-2","volume":"28","author":"DS Bai","year":"2014","unstructured":"Bai DS, Qian JJ, Chen P, Yao J, Wang XD, Jin SJ, Jiang GQ (2014) Modified laparoscopic and open splenectomy and azygoportal disconnection for portal hypertension. Surg Endosc 28:257\u2013264","journal-title":"Surg Endosc"},{"key":"12330_CR22","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.ijsu.2019.02.018","volume":"64","author":"DS Bai","year":"2019","unstructured":"Bai DS, Xia BL, Zhang C, Ye J, Qian JJ, Jin SJ, Jiang GQ (2019) Warfarin versus aspirin prevents portal vein thrombosis after laparoscopic splenectomy and azygoportal disconnection: a randomized clinical trial. Int J Surg 64:16\u201323","journal-title":"Int J Surg"},{"key":"12330_CR23","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1097\/01.sla.0000151794.28392.a6","volume":"241","author":"M Ikeda","year":"2005","unstructured":"Ikeda M, Sekimoto M, Takiguchi S, Kubota M, Ikenaga M, Yamamoto H, Fujiwara Y, Ohue M, Yasuda T, Imamura H, Tatsuta M, Yano M, Furukawa H, Monden M (2005) High incidence of thrombosis of the portal venous system after laparoscopic splenectomy: a prospective study with contrast-enhanced CT scan. Ann Surg 241:208\u2013216","journal-title":"Ann Surg"},{"key":"12330_CR24","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.jhep.2009.03.013","volume":"51","author":"MA Zocco","year":"2009","unstructured":"Zocco MA, Di Stasio E, De Cristofaro R, Novi M, Ainora ME, Ponziani F, Riccardi L, Lancellotti S, Santoliquido A, Flore R, Pompili M, Rapaccini GL, Tondi P, Gasbarrini GB, Landolfi R, Gasbarrini A (2009) Thrombotic risk factors in patients with liver cirrhosis: correlation with MELD scoring system and portal vein thrombosis development. J Hepatol 51:682\u2013689","journal-title":"J Hepatol"},{"key":"12330_CR25","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1016\/j.jhep.2017.07.002","volume":"67","author":"R Carnevale","year":"2017","unstructured":"Carnevale R, Raparelli V, Nocella C, Bartimonthsccia S, Novo M, Severino A, De Falco E, Cammisotto V, Pasquale C, Crescioli C, Scavalli AS, Riggio O, Basili S, Violi F (2017) Gut-derived endotoxin stimulates factor VIII secretion from endothelial cells. Implications for hypercoagulability in cirrhosis. J Hepatol 67:950\u2013956","journal-title":"J Hepatol"},{"key":"12330_CR26","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1161\/01.CIR.0000063575.17904.4E","volume":"107","author":"J Hirsh","year":"2003","unstructured":"Hirsh J, Fuster V, Ansell J, Halperin JL, American Heart Association, American College of Cardiology Foundation (2003) American Heart Association\/American College of Cardiology Foundation guide to warfarin therapy. Circulation 107:1692\u20131711","journal-title":"Circulation"},{"key":"12330_CR27","doi-asserted-by":"publisher","first-page":"483","DOI":"10.2165\/00003088-198611060-00005","volume":"11","author":"NH Holford","year":"1986","unstructured":"Holford NH (1986) Clinical pharmacokinetics and pharmacodynamics of warfarin. Understanding the dose-effect relationship. Clin Pharmacokinet 11:483\u2013504","journal-title":"Clin Pharmacokinet"},{"key":"12330_CR28","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1111\/bcp.14404","volume":"87","author":"CSS Tan","year":"2021","unstructured":"Tan CSS, Lee SWH (2021) Warfarin and food, herbal or dietary supplement interactions: a systematic review. Br J Clin Pharmacol 87:352\u2013374","journal-title":"Br J Clin Pharmacol"},{"key":"12330_CR29","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1002\/j.1875-9114.2012.01119","volume":"32","author":"A Nadkarni","year":"2012","unstructured":"Nadkarni A, Oldham MA, Howard M, Berenbaum I (2012) Drug-drug interactions between warfarin and psychotropics: updated review of the literature. Pharmacotherapy 32:932\u2013942","journal-title":"Pharmacotherapy"},{"key":"12330_CR30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0164076","volume":"11","author":"S Haas","year":"2016","unstructured":"Haas S, Ten Cate H, Accetta G, Angchaisuksiri P, Bassand JP, Camm AJ, Corbalan R, Darius H, Fitzmaurice DA, Goldhaber SZ, Goto S, Jacobson B, Kayani G, Mantovani LG, Misselwitz F, Pieper K, Schellong SM, Stepinska J, Turpie AG, van Eickels M, Kakkar AK, GARFIELD-AF Investigators (2016) Quality of vitamin K antagonist control and 1-year outcomes in patients with atrial fibrillation: a global perspective from the GARFIELD-AF registry. PLoS ONE 11:e0164076","journal-title":"PLoS ONE"},{"key":"12330_CR31","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1161\/CIRCOUTCOMES.113.000817","volume":"7","author":"LM Efird","year":"2014","unstructured":"Efird LM, Mishkin DS, Berlowitz DR, Ash AS, Hylek EM, Ozonoff A, Reisman JI, Zhao S, Jasuja GK, Rose AJ (2014) Stratifying the risks of oral anticoagulation in patients with liver disease. Circ Cardiovasc Qual Outcomes 7:461\u2013467","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"12330_CR32","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1124\/dmd.108.023143","volume":"37","author":"N Raghavan","year":"2009","unstructured":"Raghavan N, Frost CE, Yu Z, He K, Zhang H, Humphreys WG, Pinto D, Chen S, Bonacorsi S, Wong PC, Zhang D (2009) Apixaban metabolism and pharmacokinetics after oral administration to humans. Drug Metab Dispos 37:74\u201381","journal-title":"Drug Metab Dispos"},{"key":"12330_CR33","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1111\/j.1365-2125.2012.04369.x","volume":"75","author":"C Frost","year":"2013","unstructured":"Frost C, Wang J, Nepal S, Schuster A, Barrett YC, Mosqueda-Garcia R, Reeves RA, LaCreta F (2013) Apixaban, an oral, direct factor Xa inhibitor: single dose safety, pharmacokinetics, pharmacodynamics and food effect in healthy subjects. Br J Clin Pharmacol 75:476\u2013487","journal-title":"Br J Clin Pharmacol"},{"key":"12330_CR34","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines9050445","volume":"9","author":"C Dunois","year":"2021","unstructured":"Dunois C (2021) Laboratory monitoring of direct oral anticoagulants (DOACs). Biomedicines 9:445","journal-title":"Biomedicines"},{"key":"12330_CR35","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1093\/rheumatology\/kev445","volume":"55","author":"S Sciascia","year":"2016","unstructured":"Sciascia S, Lopez-Pedrera C, Cecchi I, Pecoraro C, Roccatello D, Cuadrado MJ (2016) Non-vitamin K antagonist oral anticoagulants and antiphospholipid syndrome. Rheumatology (Oxford) 55:1726\u20131735","journal-title":"Rheumatology (Oxford)"},{"key":"12330_CR36","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1056\/NEJMoa1607887","volume":"375","author":"SJ Connolly","year":"2016","unstructured":"Connolly SJ, Milling TJ Jr, Eikelboom JW, Gibson CM, Curnutte JT, Gold A, Bronson MD, Lu G, Conley PB, Verhamme P, Schmidt J, Middeldorp S, Cohen AT, Beyer-Westendorf J, Albaladejo P, Lopez-Sendon J, Goodman S, Leeds J, Wiens BL, Siegal DM, Zotova E, Meeks B, Nakamya J, Lim WT, Crowther M, ANNEXA-4 Investigators (2016) Andexanet alfa for acute major bleeding associated with factor Xa inhibitors. N Engl J Med 375:1131\u20131141","journal-title":"N Engl J Med"},{"key":"12330_CR37","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1001\/jamacardio.2017.0065","volume":"2","author":"PA Cowper","year":"2017","unstructured":"Cowper PA, Sheng S, Lopes RD, Anstrom KJ, Stafford JA, Davidson-Ray L, Al-Khatib SM, Ansell J, Dorian P, Husted S, McMurray JJV, Steg PG, Alexander JH, Wallentin L, Granger CB, Mark DB (2017) Economic analysis of Apixaban therapy for patients with atrial fibrillation from a US perspective: results from the ARISTOTLE randomized clinical trial. JAMA Cardiol 2:525\u2013534","journal-title":"JAMA Cardiol"},{"key":"12330_CR38","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1007\/s11239-019-02035-0","volume":"50","author":"KA Davis","year":"2020","unstructured":"Davis KA, Joseph J, Nisly SA (2020) Direct oral anticoagulants and warfarin in patients with cirrhosis: a comparison of outcomes. J Thromb Thrombolysis 50:457\u2013461","journal-title":"J Thromb Thrombolysis"},{"key":"12330_CR39","doi-asserted-by":"publisher","first-page":"662","DOI":"10.14423\/SMJ.0000000000001750","volume":"117","author":"SP Prince","year":"2024","unstructured":"Prince SP, Dayto DC, Sephien A, Lozano M, Tobillo R, Hurlock NP, Ram A, Abernathy J (2024) Efficacy and safety of direct oral anticoagulants compared to warfarin in patients with cirrhosis and splanchnic vein thrombosis. South Med J 117:662\u2013665","journal-title":"South Med J"}],"container-title":["Surgical Endoscopy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00464-025-12330-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00464-025-12330-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00464-025-12330-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T19:32:46Z","timestamp":1769023966000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00464-025-12330-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,23]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["12330"],"URL":"https:\/\/doi.org\/10.1007\/s00464-025-12330-y","relation":{},"ISSN":["0930-2794","1432-2218"],"issn-type":[{"value":"0930-2794","type":"print"},{"value":"1432-2218","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,23]]},"assertion":[{"value":"8 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Tian-Ming Gao, Kun-Qing Xiao, Liu-Xin Zhou, Bing-Bing Su, Sheng-Jie Jin, Chi Zhang, Bao-Huan Zhou, Dou-Sheng Bai, and Guo-Qing Jiang have no conflicts of interest or financial ties to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}},{"value":"The study was approved by ethics board of the Clinical Medical College of author's University. Each participant in the study provided informed consent to participate in the research and for the use of their data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}